Digestive/gut health ranks as the most popular active health positioning, from global product launch activity tracked by Innova Market Insights in 2010, constituting 26.7% of active health* product launches.
Research by experts from the University of Bristol has unleashed a scientific design for a probiotic that may be used for the treatment of inflammatory bowel disease (IBD) like Crohn’s disease.
UAS Laboratories Inc. has recently introduced condition-specific, probiotic blends. UAS Labs’ Premium DDS Probiotic Blends, containing the super strain Lactobacillus acidophilus DDS®-1, have demonstrated condition-specific health benefits.
Soluble and insoluble dietary fiber, probiotics and enzymes all can play a role in gastrointestinal health. Marketing those benefits to consumers can be challenging.
Stratum Nutrition's chitin-glucan fiber ingredient, Artinia(TM) has received self-affirmed generally recognized as safe (GRAS) status. Following a comprehensive review of the safety, toxicology and proposed usage, an independent panel of experts reached a unanimous decision supporting the use of Artinia in a wide range of food and beverage products.
A new clinical trial study suggests that FenuLife®, marketed by Frutarom Inc., as an aid to improve blood glucose response, is also a safe alternative to pharmaceutical acid-reflux and heartburn medications.